Literature DB >> 10877931

Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.

H Nishino1, H Hida, N Takei, M Kumazaki, K Nakajima, H Baba.   

Abstract

Epidermal growth factor (EGF)/fibroblast growth factor (FGF)-responsive stem (progenitor) cells from embryonic brain have self-renewing and multipotent properties and thus are good candidates for donor cells in neural transplantation. However, the survival and differentiation to mature neurons after grafting of stem cells into adult brain are rather poor. We hypothesize that the differentiation of stem cells to mature neurons, such as dopaminergic (DAergic) neurons, is dependent on environmental cues that control the ontogenic development. We compared the survival and differentiation between mesencephalic (MS) and cortical (CTx) stem (progenitor) cells, following grafting into bilateral striata of hemiparkinsonian model rats. MS and CTx stem cells were prepared from E12 rats and proliferated in serum-free medium with EGF or basic FGF for 2 weeks. One day after being primed to differentiate, the cell suspensions of both origins were grafted into the bilateral striata of adult rats that had unilateral 6-OHDA lesions in the substantia nigra. MS cells differentiated to tyrosine hydroxylase (TH)-positive neurons more strongly in DA-depleted striatum than in intact striatum, and methamphetamine-induced rotation was ameliorated in half of the grafted animals. Rosette-like cell aggregation and dysfunction of the blood-brain barrier (BBB) were less in and around the grafts in DA-depleted striatum, suggesting less proliferation and more differentiation of MS stem cells in DA-depleted striatum. Neither TH-positive neurons nor behavioral amelioration were detected following CTx stem (progenitor) cell transplantation in the striata. Data suggest that the DA-depleted striatum offers a suitable environment for MS stem (progenitor) cells to differentiate into mature DAergic neurons. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877931     DOI: 10.1006/exnr.2000.7426

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  15 in total

Review 1.  Stem cell and precursor cell therapy.

Authors:  Jingli Cai; Mahendra S Rao
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

2.  Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene.

Authors:  K Sawamoto; N Nakao; K Kakishita; Y Ogawa; Y Toyama; A Yamamoto; M Yamaguchi; K Mori; S A Goldman; T Itakura; H Okano
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

3.  Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors.

Authors:  Kaneyasu Nishimura; Shigeo Murayama; Jun Takahashi
Journal:  Stem Cells Transl Med       Date:  2015-06-03       Impact factor: 6.940

Review 4.  The Role of Direct Current Electric Field-Guided Stem Cell Migration in Neural Regeneration.

Authors:  Li Yao; Yongchao Li
Journal:  Stem Cell Rev Rep       Date:  2016-06       Impact factor: 5.739

Review 5.  Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.

Authors:  Ajay Kumar; Karthikeyan Narayanan; Ravi Kumar Chaudhary; Sachin Mishra; Sundramurthy Kumar; Kumar Jayaseelan Vinoth; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

6.  Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.

Authors:  Ming Yang; Angela E Donaldson; Cheryl E Marshall; James Shen; Lorraine Iacovitti
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

7.  Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells.

Authors:  Ming Yang; Angela E Donaldson; Yubao Jiang; Lorraine Iacovitti
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 8.  Preclinical assessment of stem cell therapies for neurological diseases.

Authors:  Valerie L Joers; Marina E Emborg
Journal:  ILAR J       Date:  2009

9.  Development of stem cell-based therapy for Parkinson's disease.

Authors:  Fabin Han; Deborah Baremberg; Junyu Gao; Jing Duan; Xianjie Lu; Nan Zhang; Qingfa Chen
Journal:  Transl Neurodegener       Date:  2015-09-03       Impact factor: 8.014

Review 10.  Potential sources of stem cells as a regenerative therapy for Parkinson's disease.

Authors:  Abir Oueida El-Sadik
Journal:  Stem Cells Cloning       Date:  2010-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.